| 注册
首页|期刊导航|中国伤残医学|卡马西平联合敏使朗治疗前庭阵发症的疗效观察

卡马西平联合敏使朗治疗前庭阵发症的疗效观察

李建辉

中国伤残医学Issue(10):41-42,2.
中国伤残医学Issue(10):41-42,2.

卡马西平联合敏使朗治疗前庭阵发症的疗效观察

Efficacy of carbamazepine combined with mestilate in treatment of vestibular paroxysmia

李建辉1

作者信息

  • 1. 河南科技大学二附院神经内科,河南 洛阳 471000
  • 折叠

摘要

Abstract

Objective:To evaluate the clinical efficiency of carbamazepine combined with mestilate for treatment of vestibular paroxys -mia.Methods:Eighty-six patients suffering from vestibular paroxysmia were underwent the research , they were randomly divided into two groups, the carbamazepine combined with mestilate group (43case) and the carbmazepine group(43case), the efficacy of the two groups were observed .Results:The efficiency rate in the carbamazepine combined with mestilate group was higher than the carbamazepine group (P<0.05).The side effects of carbamazepine combined with mestilate group were generally mild .Conclusion:Carbamazepine combined with mestilate in treatment of vestibular paroxysmia had good clinical curative effect , highly safety , should be worth clinical use.

关键词

卡马西平/敏使朗/前庭阵发症/疗效

Key words

Carbamazepine/Mestilate/Vestibular paroxysmia/Efficiency

分类

医药卫生

引用本文复制引用

李建辉..卡马西平联合敏使朗治疗前庭阵发症的疗效观察[J].中国伤残医学,2013,(10):41-42,2.

中国伤残医学

1673-6567

访问量0
|
下载量0
段落导航相关论文